Bio-Techne Hisse

Bio-Techne EBITDA

Bio-Techne (TECH) öğesinin EBITDA (Faiz, Vergi, Amortisman Öncesi Kâr) değeri 11 Ağu 2026 itibarıyla 138,27 M USD dir. Önceki yılda, EBITDA (Faiz, Vergi, Amortisman Öncesi Kâr) 239,89 M USD idi — -42,36% (daha düşük) bir değişiklik.

EBITDA

138,27 MUSD

YoY

-42,36%

Son güncelleme:

Bio-Techne öğesinin EBITDA (Faiz, Vergi, Amortisman Öncesi Kâr) değeri 2026 138,27 M USD dir. Bio-Techne öğesinin EBITDA (Faiz, Vergi, Amortisman Öncesi Kâr) değeri 2025 239,89 M USD idi. %-42,36 daha düşük önceki yıla kıyasla azalmaktadır.
Access this data via the Eulerpool API

Bio-Techne Hisse senedi analizi

Bio-Techne ne yapar? Bio-Techne Corp is a global company specializing in the research and development of innovative products and solutions in the field of biosciences. The company was founded in 1976 in Minneapolis and was formerly known as Techne Corporation. Since then, it has grown into an internationally renowned company through its numerous acquisitions and mergers. The company is headquartered in Minneapolis, Minnesota, USA. The business philosophy of Bio-Techne Corp is to help bioscientific researchers and clinicians around the world perform their work more effectively, efficiently, and quickly. The company works closely with its customers to provide them with suitable products and services, thereby developing innovative solutions to the challenges in bioscience. Bio-Techne Corp has various business segments, including protein platforms, diagnostics, genetic analysis, clinical controls, cell culture products, and research reagents. Each business segment offers a variety of products and services to support researchers and clinicians in their work. A key business segment of Bio-Techne Corp is the protein platform, which offers a comprehensive range of proteins, antibodies, and corresponding detection reagents. The company is known for its high-quality proteins and antibodies, which contribute to improving the research of diseases such as cancer, diabetes, and neurological and immunological disorders. Another important business segment of Bio-Techne Corp is diagnostics. Here, the company offers a wide range of clinical diagnostic products, such as tests for analyzing urea, creatinine, and bone density. The company's products help clinicians make precise diagnoses and treat patients more effectively. The genetic analysis segment offers DNA sequencing, gene expression, and genome-wide analysis products and services. These tools enable researchers to better understand the functioning of the human body by exploring the underlying genetic changes. The clinical controls segment offers product and service offerings that improve the reliability and accuracy of diagnostic systems. The company works closely with medical facilities to provide diagnostic solutions that deliver fast and accurate results. The cell culture products segment offers a complete range of solutions for cell cultivation and growth. The offering ranges from basic nutrient media and additives to culture vessels and accessories. The company's products enable researchers to culture cells in a controlled environment and under precise conditions. The last segment of Bio-Techne Corp includes research reagents. Here, the company offers a wide range of reagents used for protein, antibody, and cell function analysis and research. The products meet the needs of researchers in modern bioscience. In summary, Bio-Techne Corp is a company specialized in developing innovative solutions in bioscience, advancing science and medicine. With its products and services offered in various sectors, the company successfully helps researchers and clinicians perform their work faster, more effectively, and cost-efficiently. Bio-Techne, Eulerpool'daki en popüler şirketlerden biridir.

Bio-Techne hisse senedi hakkında sık sorulan sorular

Bio-Techne şirketinin EBITDA (Faiz, Vergi, Amortisman Öncesi Kâr) değeri 2026 yılında 138,27 M USD.

Bio-Techne öğesinin EBITDA (Faiz, Vergi, Amortisman Öncesi Kâr) değeri 239,89 M USD değerinden 138,27 M USD değerine değişmiş ve bu %-42,36 değişimi temsil etmektedir. Değer önceki yıldan daha düşük dir.

Eulerpool'da EBITDA (Faiz, Vergi, Amortisman Öncesi Kâr) öğesinin Bio-Techne değerinin 2006'dan itibaren tam tarihsel gelişimini bulabilirsiniz — yıllık değerler, grafikler ve ayrıntılı analiz ile.

EBITDA, finansal yapı, vergi ortamı ve nakit olmayan amortisman giderleri etkisinden önceki işletme performansını ölçer.

EBITDA = EBIT + Amortisman

EBITDA (Faiz, Vergi, Amortisman Öncesi Kâr)'nin USD, yatırımcılar için kilit bir faktördür. Bu metrikte yapılan değişiklikler temel faktörlerin iyileşmesini veya kötüleşmesini gösterebilir ve hisse senedi fiyatını doğrudan etkiler. Eulerpool'da EBITDA (Faiz, Vergi, Amortisman Öncesi Kâr)'nin Bio-Techne değerini tarihsel olarak ve gerçek zamanlı olarak takip edebilirsiniz.

Access this data via the Eulerpool API

Gelir Tablosu — Bio-Techne

Tüm Kilit Metrikler — Bio-Techne